Serotonergic mechanisms in human allergic contact dermatitis

Area of Science:

• Immunology
• Dermatology
• Neuroscience

Background:

• Nickel allergy is a common contact hypersensitivity.
• The role of the serotonergic system in allergic contact dermatitis is not fully understood.
• Serotonin (5-hydroxytryptamine; 5-HT) and its associated proteins are implicated in immune responses.

Purpose of the Study:

• To investigate the expression of serotonin, 5-HT receptors (5-HT1AR, 5-HT2AR), and serotonin transporter protein (SERT) in nickel-allergic reactions.
• To examine the effects of serotonergic agents on immune cells involved in nickel allergy.

Main Methods:

• Analysis of serotonin, 5-HT1AR, 5-HT2AR, and SERT expression in skin biopsies from nickel-allergic patients.
• In vitro testing of 5-HT2AR agonist DOI and SSRIs (citalopram, fluoxetine) on nickel-stimulated peripheral blood mononuclear cells (PBMCs).
• Assessment of PBMC proliferation, IL-2 production, and IL-1beta production in a murine cell line (XS52).

Main Results:

• Increased serotonin-positive platelets and elevated 5-HT2AR and SERT-positive cells in inflamed allergic skin.
• Decreased 5-HT1AR-positive cells in eczematous skin.
• DOI inhibited nickel-stimulated PBMC proliferation; citalopram showed a trend towards inhibiting IL-1beta production.

Conclusions:

• The serotonergic system is involved in the pathogenesis of allergic contact reactions to nickel.
• Alterations in serotonin and its transporter/receptor expression correlate with nickel-induced skin inflammation.
• Serotonergic modulation may represent a potential therapeutic target for contact allergies.